Don’t wait for the plate^™

At Avails, we understand the urgent threat of antimicrobial resistance and the need for diagnostic solutions. Our rapid AST technology reduces the time to effective treatment for life-threatening infections, improving patient outcomes by eliminating days of unnecessary waiting.

Don’t wait for the plate™

Transforming diagnostics through innovation & technology

Our novel, patented electronic biosensor platforms are poised to become the new gold standard in the infectious disease diagnostic space. We offer the most intuitive and compact solutions that can be readily integrated into every healthcare setting.

Antibiotic resistance is a global challenge

30% to 60%

of antibiotics prescribed in ICUs are inappropriate, suboptimal, or unnecessary1-3

Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J: DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients?. Clin Infect Dis. 2014, 58: 1072-1083.
Kollef MH: Optimizing antibiotic therapy in the intensive care unit setting. Crit Care. 2001, 5: 189-195.
Kollef MH, Fraser VJ: Antibiotic resistance in the intensive care unit. Ann Intern Med. 2001, 134: 298-314.

A better way forward with Avails Medical

For clinical microbiology laboratories in search of faster AST solutions, our compact biosensor technology platforms provide more timely answers compared to conventional methods so that in a space where minutes matter, patient care teams can act more rapidly to confidently provide the most effective antibiotic therapy to their patients. Ultimately, this can enhance patient outcomes, reduce the burden of hospitalization costs and thwart the emerging antimicrobial resistance crisis.